Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

Hubei Goto Biopharm Statistics

Total Valuation

SHE:300966 has a market cap or net worth of CNY 3.16 billion. The enterprise value is 4.48 billion.

Market Cap	3.16B
Enterprise Value	4.48B

Important Dates

The last earnings date was Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:300966 has 115.08 million shares outstanding. The number of shares has increased by 1.58% in one year.

Current Share Class	115.08M
Shares Outstanding	115.08M
Shares Change (YoY)	+1.58%
Shares Change (QoQ)	-3.93%
Owned by Insiders (%)	44.74%
Owned by Institutions (%)	3.88%
Float	54.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.02
PB Ratio	3.47
P/TBV Ratio	4.07
P/FCF Ratio	n/a
P/OCF Ratio	45.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.57, with an EV/FCF ratio of -111.45.

EV / Earnings	-62.90
EV / Sales	7.13
EV / EBITDA	42.57
EV / EBIT	n/a
EV / FCF	-111.45

Financial Position

The company has a current ratio of 0.99, with a Debt / Equity ratio of 1.45.

Current Ratio	0.99
Quick Ratio	0.37
Debt / Equity	1.45
Debt / EBITDA	12.36
Debt / FCF	-32.78
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8.31% and return on invested capital (ROIC) is -1.26%.

Return on Equity (ROE)	-8.31%
Return on Assets (ROA)	-0.58%
Return on Invested Capital (ROIC)	-1.26%
Return on Capital Employed (ROCE)	-1.30%
Weighted Average Cost of Capital (WACC)	4.79%
Revenue Per Employee	769,767
Profits Per Employee	-87,200
Employee Count	817
Asset Turnover	0.22
Inventory Turnover	1.18

Taxes

Income Tax	-22.27M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.10% in the last 52 weeks. The beta is 0.46, so SHE:300966's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+66.10%
50-Day Moving Average	22.04
200-Day Moving Average	21.78
Relative Strength Index (RSI)	71.32
Average Volume (20 Days)	5,510,624

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300966 had revenue of CNY 628.90 million and -71.24 million in losses. Loss per share was -0.62.

Revenue	628.90M
Gross Profit	86.74M
Operating Income	-26.88M
Pretax Income	-102.11M
Net Income	-71.24M
EBITDA	106.57M
EBIT	-26.88M
Loss Per Share	-0.62

Balance Sheet

The company has 75.48 million in cash and 1.32 billion in debt, with a net cash position of -1.24 billion or -10.80 per share.

Cash & Cash Equivalents	75.48M
Total Debt	1.32B
Net Cash	-1.24B
Net Cash Per Share	-10.80
Equity (Book Value)	910.61M
Book Value Per Share	7.78
Working Capital	-8.04M

Cash Flow

In the last 12 months, operating cash flow was 69.91 million and capital expenditures -110.12 million, giving a free cash flow of -40.21 million.

Operating Cash Flow	69.91M
Capital Expenditures	-110.12M
Depreciation & Amortization	133.45M
Net Borrowing	82.38M
Free Cash Flow	-40.21M
FCF Per Share	-0.35

Margins

Gross margin is 13.79%, with operating and profit margins of -4.27% and -11.33%.

Gross Margin	13.79%
Operating Margin	-4.27%
Pretax Margin	-16.24%
Profit Margin	-11.33%
EBITDA Margin	16.95%
EBIT Margin	-4.27%
FCF Margin	n/a

Dividends & Yields

SHE:300966 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.58%
Shareholder Yield	-1.58%
Earnings Yield	-2.26%
FCF Yield	-1.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3